ARCHITECT ANTI-HCV
Report
- Report Number
- 3002809144-2016-00091
- Event Type
- Malfunction
- Date Received
- October 24, 2016
- Date of Event
- September 14, 2016
- Report Date
- November 14, 2016
- Manufacturer
- ABBOTT GERMANY
- Product Code
- MZO
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AS
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.
EVALUATION OF THE CUSTOMER ISSUE INCLUDED A REVIEW OF THE COMPLAINT TEXT, A SEARCH FOR SIMILAR COMPLAINTS, A REVIEW OF LABELING AND ACCURACY TESTING. NO ADVERSE TREND WAS IDENTIFIED FOR THE CUSTOMER'S ISSUE. DEVICE HISTORY REVIEW DID NOT IDENTIFY ANY ISSUES THAT MAY HAVE CAUSED THE CUSTOMER ISSUE. LABELING WAS REVIEWED AND FOUND TO BE ADEQUATE. THE PRODUCT WAS NOT AVAILABLE FOR RETURN. AN INTERNAL PANEL WAS TESTED WITH RETAINED KITS AND ACCURACY TESTING MET ALL SPECIFICATIONS. BASED ON ALL AVAILABLE INFORMATION AND ABBOTT DIAGNOSTICS COMPLAINT INVESTIGATION, THE ASSAY PERFORMED AS INTENDED AND NO PRODUCT DEFICIENCY WAS IDENTIFIED.
THE CUSTOMER REPORTED (B)(6) RESULTS GENERATED USING THE ARCHITECT (B)(6) REAGENTS. THE FOLLOWING DATA WAS PROVIDED FOR ONE PATIENT (S/CO). SID (B)(6) INITIAL (B)(6), RETEST (B)(6). SAMPLE RETEST USING OTHER METHODS WAS RNA NEGATIVE AND (B)(6), HOWEVER THE SPECIFIC METHOD FOR THE RETEST ANTI-HCV REACTIVE RESULT WAS NOT PROVIDED. SID (B)(6) (REDRAWN SAMPLE) (B)(6). NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 702996 | ARCHITECT ANTI-HCV | ANTI-HCV | MZO | ABBOTT GERMANY | 62280LI00 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | ARCHITECT I2000 ANALYZER| LIST NUMBER 03M74-01| SERIAL NUMBER (B)(4) |